CellVoyant Information

CellVoyant is an AI-first biotechnology company building platforms for predictive cell analytics and AI-guided process optimisation. In cell-based development, decisions are often made too late, and unpredictable cell behaviour makes manufacturing complex, costly, and difficult to scale. As a result, promising development programmes can fail when processes lack predictability and control. Using standard, label-free microscopy images, our technology infers cell state and anticipates future performance—bringing quantitative insight earlier in the workflow and enabling more reliable optimisation. Our product ecosystem includes FateView™, a cloud-based platform for predictive cell analytics, and FateDrive™, an AI-guided optimisation service for improving yield, quality, and reproducibility. Our mission is to make cell development predictive rather than reactive—reducing failed experiments and accelerating therapeutic progress. CellVoyant is backed by venture investors with deep experience in AI and life sciences, including early backers of DeepMind, Exscientia, Recursion, and Wayve, as well as the founder and CEO of Abcam.